NOS2 and dementia: As inflammation plays a decisive role in neurodegeneration, which can be induced by Aβ25–35 [35], the ability of melittin to normalize iNOS protein overexpression further confirms the effect of this candidate drug on suppressing dementia development in an in vivo model.